Suppressor of Cytokine Signaling-1 (SOCS-1) Suppresses Tumor Necrosis Factor ␣-Induced Cell Death in Fibroblasts

Total Page:16

File Type:pdf, Size:1020Kb

Suppressor of Cytokine Signaling-1 (SOCS-1) Suppresses Tumor Necrosis Factor ␣-Induced Cell Death in Fibroblasts Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)͞suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor ␣-induced cell death in fibroblasts Yoshiaki Morita*†, Tetsuji Naka*, Yoshinori Kawazoe*, Minoru Fujimoto*, Masashi Narazaki*, Reiko Nakagawa‡, Hidehiro Fukuyama§, Shigekazu Nagata§, and Tadamitsu Kishimoto¶ʈ Departments of *Medicine III, ‡Microbiology, and §Genetics, Osaka University Medical School, 2-2, Yamada-oka, Suita-city, Osaka 565-0871, Japan; ¶Osaka University, 1-1 Yamada-oka, Suita-city, Osaka 565-0871, Japan; and †Department of Immunology and Inflammation Medicinal Biology Research Laboratory, Fujisawa Pharmaceutical Company, Ltd., 1-6 Kashima 2 Chome Yodogawa-ku, Osaka 532-8514, Japan Contributed by Tadamitsu Kishimoto, February 28, 2000 Signal transducers and activators of transcription (STAT)-induced Ϫ͞Ϫ mice. Moreover, murine embryonic fibroblasts (MEFs) STAT inhibitor-1 [SSI-1; also known as suppressor of cytokine lacking the SSI-1 gene become sensitive to TNF-␣-induced cell signaling-1 (SOCS-1)] was identified as a negative feedback regu- death. In contrast, L929 cells forced to express SSI-1 (L929͞ lator of Janus kinase-STAT signaling. We previously generated SSI-1) show resistance to TNF-␣-induced cell death. In addition, mice lacking the SSI-1 gene (SSI-1 ؊͞؊) and showed that thymo- SB203580, a highly specific inhibitor of p38 mitogen-activated cytes and splenocytes in SSI-1 ؊͞؊ mice underwent accelerated protein (MAP) kinase, eliminates resistance to TNF-␣-induced apoptosis. In this paper, we show that murine embryonic fibro- cell death in L929͞SSI-1 cells. Also, SSI-1 is revealed to relate blasts lacking the SSI-1 gene are more sensitive than their litter- to the activation of p38 MAP kinase. Other families of SSI, mate controls to tumor necrosis factor-␣ (TNF-␣)-induced cell however, such as SSI-3 and SOCS-5, do not show these effects. death. In addition, L929 cells forced to express SSI-1 (L929͞SSI-1), The primary nature of SSI-1 is a negative feedback regulator of but not SSI-3 or SOCS-5, are resistant to TNF-␣-induced cell death. JAK-STAT signaling. However, the experiment using STAT1 Furthermore L929͞SSI-1 cells treated with TNF-␣ sustain the acti- Ϫ͞Ϫ or STAT6 Ϫ͞Ϫ MEFs reveals that JAK-STAT signaling is vation of p38 mitogen-activated protein (MAP) kinase. In contrast, not related to TNF-␣-induced cell death signals. Thus, our SSI-1 ؊͞؊ murine embryonic fibroblasts treated with TNF-␣ show results show that SSI-1 suppresses TNF-␣-induced cell death hardly any activation of p38 MAP kinase. These findings suggest through regulation of p38 MAP kinase instead of through that SSI-1 suppresses TNF-␣-induced cell death, which is mediated regulation of JAK-STAT signaling, and they reveal an important by p38 MAP kinase signaling. role of SSI-1 on TNF-␣ signaling. ytokines play important roles in controlling homeostasis of Materials and Methods Corganisms through cell differentiation, proliferation, and Measurement of Serum TNF-␣, IFN-␥, and IL-1␤. Whole blood was apoptosis, and these effects are mainly brought about by Janus collected from SSI-1 Ϫ͞Ϫ mice or SSI-1 ϩ͞ϩ mice under kinase-signal transducers and activators of transcription (JAK- anesthesia at 10 days after birth, and then was centrifuged. STAT) signaling. Serum of SSI-1 ϩ͞ϩ mice injected intravenously with Con A at Recently, several groups independently have cloned negative a dose of 10 ␮g͞g of body weight was used as positive control. feedback regulators of JAK-STAT signaling. STAT-induced The serum was stored at Ϫ80°C. TNF-␣ serum samples were STAT inhibitor-1 (SSI-1)͞suppressor of cytokine signaling-1 measured by using a mouse TNF-␣ ELISA kit (Genzyme) (SOCS-1) is known as one of the negative feedback regulators of according to the manufacturer’s instructions. IFN-␥ or IL-1␤ was JAK-STAT signaling (1–3). SSI-1 is induced by various cyto- measured with an ELISA kit (BioSource International, Cama- kines, such as IL-2, IL-3, IL-4, IL-6, IL-13, granulocyte– rillo, CA). macrophage colony-stimulating factor, erythropoietin, IFN-␥, and leukemia inhibitory factor, can bind to all four members of Plasmid Construction and DNA Transfection. Mouse SSI-1 cDNA the JAKs, and inhibits signals of various cytokines by suppressing was subcloned into the mammalian vector pEF-BOS and ex- the activation of the JAKs (4). However, the specificity of SSI-1 pressed under the control of an elongation factor gene promoter. for the JAKs in vitro is not well defined. SSI-1 has two charac- An Arg-105 point mutation of SSI-1 yielding Gln was introduced teristic domains, an Src homology 2 domain and a carboxyl- by using a quick-change site-directed mutagenesis kit (Strat- terminal conserved domain, which we have called the SC-motif (also referred to as the SOCS box). So far the cloned SSI families (5–6) comprise at least eight members on the basis of the two Abbreviations: STAT, signal transducers and activators of transcription; SSI-1, STAT-induced characteristic domains, even if overlapping is excluded. STAT inhibitor-1; SOCS-1, suppressor of cytokine signaling-1; TNF-␣, tumor necrosis fac- tor-␣; JAK, Janus kinase; MEFs, murine embryonic fibroblasts; RQ, an Arg-105 point muta- Our previous study revealed that mice lacking the SSI-1 gene tion of SSI-1 yielding Gln; TRAF, TNF receptor-associated factor; MAP kinase, mitogen- (SSI-1 Ϫ͞Ϫ) were healthy and normal at birth, but exhibited activated protein kinase; MKK, MAP kinase kinase; ERK, extracellular signal-regulated growth retardation with aging and died within 3 weeks after birth kinase; JNK, c-Jun amino-terminal kinase; ATF2, activating transcription factor 2; WST-8, (7). In addition, lymphocytes underwent accelerated apoptosis in 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium; 1-methoxy-PMS, 1-methoxyphenazine methosulfate. lymphoid organs such as thymus and spleen of SSI-1 Ϫ͞Ϫ mice ʈTo whom reprint requests should be sent at ¶ address. E-mail: [email protected] at 10 days after birth. Because apoptosis generally is brought u.ac.jp. about by death signals, which are produced from tumor necrosis ␣ ␣ The publication costs of this article were defrayed in part by page charge payment. This factor- (TNF- ) or FasL signaling, it was thought that accel- article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. erated apoptosis of thymocytes and splenocytes in SSI-1 Ϫ͞Ϫ §1734 solely to indicate this fact. ␣ IMMUNOLOGY mice might result from dysregulated TNF- or FasL signaling. In Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073͞pnas.090084797. this study, we observe an increase in the serum TNF-␣ of SSI-1 Article and publication date are at www.pnas.org͞cgi͞doi͞10.1073͞pnas.090084797 PNAS ͉ May 9, 2000 ͉ vol. 97 ͉ no. 10 ͉ 5405–5410 Downloaded by guest on September 29, 2021 agene) according to the manufacturer’s instructions and desig- Table 1. Serum TNF-␣ protein levels, but not IFN-␥ or IL-1␤,of nated as RQ. Delta49 was generated by introducing two SalI sites SSI-1 ؊͞؊ mice increase in comparison with those of SSI-1 ؉͞؉ at two predetermined points of the sequence and excising the mice SalI-SalI fragment. All constructs were cloned into the pEF- Cytokine conc., pg͞ml BOS vector and confirmed by DNA sequencing. The mutants were transfected into L929 cells by electroporation in combina- Mice TNF-␣ IFN-␥ IL-1␤ tion with pSV2 neo, and neomycin-resistant clones were selected Ϫ͞Ϫ Ϯ Ͻ Ͻ ␮ ͞ SSI-1 42.8 10.2* 1.0 7.0 in DMEM supplemented with 500 g ml G418 (Nacalai Tesque, SSI-1 ϩ͞ϩ 12.7 Ϯ 4.3 Ͻ1.0 Ͻ7.0 Kyoto) and 10% FCS. Con A-injected (positive control) ND 220.1 59.7 Cytotoxicity Assays. MEFs were derived from embryonic day 16 Serum TNF-␣, IFN-␥, and IL-1␤ concentrations were determined in ten pairs embryos by the fibroblast-migration method. MEFs were grown of SSI-1 Ϫ͞Ϫ mice and their littermate controls, SSI-1 ϩ͞ϩ mice, by ELISA. Mice in DMEM supplemented with 10% FCS, 100 ␮g͞ml streptomy- were sacrificed at the age of 10 days. Cytokine protein levels are shown as ͞ mean Ϯ SE. ND, not determined. cin sulfate, 100 units ml penicillin G potassium, and MEM ␣ Ϫ͞Ϫ Ͻ nonessential amino acid solution. Cells were seeded 24 h before *Serum TNF- levels of SSI-1 mice show significant difference at P 0.1 as compared with those of SSI-1 ϩ͞ϩ mice. the assay in 96-well plates at a density of 2.5 ϫ 104 cells per well in 5% FCS growth medium. Mouse recombinant TNF-␣ (Pep- ␥ rotech, London) or mouse recombinant IFN- (Peprotech) at ␮g͞ml glutathione S-transferase͞activating transcription factor the indicated concentration was applied to the cells in the ␮ ͞ 2 (ATF2) fusion protein as a substrate at 30°C for 30 min. presence of cycloheximide at 10 g ml (Sigma). After treatment Reactions were stopped by adding a 5ϫ SDS͞PAGE sample for 24 h, cell viability was assessed with a Cell Counting Kit buffer, and the samples were run on an SDS͞PAGE gel, followed (Dojin Laboratories, Kumamoto, Japan) to count living cells by by Western blotting. Incorporation of the phosphorus residue combining 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5- into the glutathione S-transferase͞ATF2 protein was detected (2,4-disulfophenyl )-2H-tetrazolium (WST-8) and 1-methoxy- with the phospho-specific ATF2 (Thr71) antibody (NEB). phenazine methosulfate (1-methoxy-PMS). L929 cells were seeded 24 h before the assay in 96-well plates Results ϫ 4 at a density of 2.5 10 cells per well in DMEM supplemented We previously reported that thymocytes and splenocytes lacking with 10% FCS, high glucose, pyridoxine hydrochloride, and 500 Ϫ͞Ϫ ␮ ͞ the SSI-1 gene (SSI-1 ) underwent accelerated apoptosis g ml G418, without phenol red, sodium pyruvate, or L- (7).
Recommended publications
  • Shigekazu Nagata Is Better Known for His Work on Apoptosis
    © 2001 Nature Publishing Group http://medicine.nature.com NEWS Having originally researched the activities of the potent hematopeotic stimulator of bone-marrow cells, granulocyte colony stimulating factor, Shigekazu Nagata is better known for his work on apoptosis. Here, one of Japan’s most renowned biomedical scientists outlines the path that has taken him full circle: from stimulating cells to grow, to finding out how they die, to tying the two processes together. Shigekazu Nagata For a man who spends most of his time clusively activated in apoptosis. He says Charles Weissmann. He took the job be- thinking about death, Shigekazu Nagata is there are several questions left to be an- cause at that time, “almost no one was remarkably upbeat. For over a decade, he swered concerning the Fas pathway. using recombinant DNA technology in has been making a name for himself with Central among them is, how does the onco- Japan.” He credits his experience in research on apoptosis, the mechanism of gene product Bcl-2 block apoptosis? Weissman’s lab with forming the basis for programmed cell death, and during that However, he has no personal plans to work his future studies and teaching him an “or- time he has watched the field come alive. on an answer to that question, perhaps be- derliness and logical procedure” to re- “Medline publications on apoptosis have cause he has become a victim of his own search. In 1982, he returned to IMS for a risen from only a couple of hundred in success at propagating interest in cell death. short time before moving to the OBI in 1990 to over 10,000 this year,” he says with “There are so many other 1987 and then to taking up a satisfied nod.
    [Show full text]
  • A Sublethal ATP11A Mutation Associated with Neurological Deterioration Causes Aberrant Phosphatidylcholine Flipping in Plasma Membranes
    A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranes Katsumori Segawa, … , Shigeo Kure, Shigekazu Nagata J Clin Invest. 2021. https://doi.org/10.1172/JCI148005. Research In-Press Preview Cell biology Metabolism Graphical abstract Find the latest version: https://jci.me/148005/pdf A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranes Katsumori Segawa,1,16,17 Atsuo Kikuchi,2,16 Tomoyasu Noji,3 Yuki Sugiura,4 Keita Hiraga,3 Chigure Suzuki,5,6 Kazuhiro Haginoya,7,8 Yasuko Kobayashi,7,9 Mitsuhiro Matsunaga,1 Yuki Ochiai,1 Kyoko Yamada,1 Takuo Nishimura,1,18 Shinya Iwasawa,2 Wataru Shoji,10 Fuminori Sugihara,11 Kohei Nishino,12 Hidetaka Kosako,12 Masahito Ikawa,13 Yasuo Uchiyama,5,6 Makoto Suematsu,4 Hiroshi Ishikita,3 Shigeo Kure,2,14 Shigekazu Nagata1, 15* 1Laboratory of Biochemistry & Immunology, World Premier International Research Center, Immunology Frontier Research Center, 11Central Instrumentation Laboratory, Research Institute for Microbial Diseases, 13Department of Experimental Genome Research, Research Institute for Microbial Diseases, 15Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan. 2Department of Pediatrics, Tohoku University School of Medicine, 10Frontier Research Institute for Interdisciplinary Sciences, and 14Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan. 3Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. 4Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan. 5Department of Cellular and Molecular Pharmacology, and 6Department of Cellular and Neuropathology, Juntendo University Graduate School of Medicine, Tokyo, Japan. 7Department of Pediatric Neurology, Takuto Rehabilitation Center for Children, Sendai, Miyagi, Japan.
    [Show full text]
  • General Report on 8Th IDS
    General Report on 8th IDS I) Local Organizing Committee Toshiaki Hanafusa (President, First Department of Internal Medicine, Osaka Medical College) Tetsuro Kobayashi (Vice President, Third Department of Internal Medicine, Yamanashi University) Hiroshi Ikegami (Osaka University) Akihisa Imagawa (Osaka Medical College) Yasuko Uchigata (Tokyo Women’s Medical University) Eiji Kawasaki (Nagasaki University) Kaichi Kida (Ehime University) Akira Shimada (Keio University) Kazuma Takahashi (Tohoku University) Masao Nagata (Kobe University) Eiichi Makino (Ehime University) Taro Maruyama (Saitama Social Insurance Hospital) II) Overseas Speakers GS. Eisenbarth (Barbara Davis Center UCHSC, USA) E. Gale (Southmead Hospital, Bristol, UK) DM. Harlan (National Institutes of Health, USA) LC. Harrison (The Walter and Eliza Hall Institute of Medical Research, Australia) YS. Park (Hanyang University, Korea) BO. Roep (Leiden University Medical Center, the Netherlands) L. Chatenoud (Paris, France) III) Local Speakers Tadatsugu Taniguchi (Tokyo University) Shigekazu Nagata (Osaka University) Shimon Sakaguchi (Kyoto University) Jun-ichi Miyazaki (Osaka University) Shizuo Akira (Osaka University) IV) Number of Participants 75 from Japan 145 from Overseas (12 accompanying persons) 1 IDS-8 participants list Accom. Country Subtotal Member Non-Member Person Australia 9 6 3 Belgium 1 0 1 Brazil 1 0 1 Canada 4 3 1 1 Denmark 2 1 1 Finland 21 13 8 France 2 2 0 Germany 3 3 0 India 1 0 1 Israel 1 1 0 1 Italy 2 1 1 1 Japan 75 46 29 3 Korea 9 2 7 New Zealand 2 2 0 Norway 2 2 0 1 Spain 2 1 1 Sweden 17 11 6 1 The Czech Republic 2 2 0 The Netherlands 4 3 1 U.K.
    [Show full text]
  • Enhanced and Accelerated Lymphoproliferation in Fas
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2131-2136, March 1996 Biochemistry Enhanced and accelerated lymphoproliferation in Fas-null mice MASASHI ADACHI*, SACHIKO SUEMATSUt, TAKASHI SUDA*, DAISUKE WATANABE*, HIDEHIRO FUKUYAMA*, JUN OGASAWARA*, TAKASHI TANAKAt, NOBUAKI YOSHIDAt, AND SHIGEKAZU NAGATA* *Osaka Bioscience Institute, 6-2-4 Furuedai, Suita. Osaka 565. Japan, and 'Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi, Osaka 590-0)2, Japan Communicated by Charles Weissmann, Universitat Ziurich, Zutriclh, Switzerland, November 22, 1995 (received for review Jutne 26, 1995) ABSTRACT Fas is a 45-kDa membrane protein that retrovirus-into an intron of the Fas chromosomal gene transduces an apoptotic signal. The mouse lymphoprolifera- (25-28), which results in premature termination and aberrant tion (lpr) mutation is a leaky mutation of Fas. In this study, splicing of the Fas transcript. However, a small amount of we examined lymphocyte development in Fas-null mice gen- intact Fas mRNA or protein is expressed in the thymus of lpr erated by gene targeting. The Fas-/- mice progressively mice (26, 28, 29), indicating that the lpr mutation is leaky (25). accumulated abnormal T cells (Thyll, B220+, CD4-, and Therefore, it was thought that the absence in lpr mice of altered CD8-) and developed lymphadenopathy and splenomegaly, thymic cell development was related to the leakiness of the which were much more accelerated and pronounced than mutation (29). those in lpr mice. In addition, the Fas-null mice showed To overcome this problem, we created Fas-knockout mice lymphocytosis, accompanied by lymphocytic infiltration in and found that they developed hepatomegaly in addition to the lungs and liver.
    [Show full text]
  • World Premier International Research Center Initiative (WPI) FY2014 WPI Project Progress Report (Post-Interim Evaluation)
    World Premier International Research Center Initiative (WPI) FY2014 WPI Project Progress Report (Post-Interim Evaluation) Host Institutio n Osaka University Host Institution Head Toshio Hirano Research Cente r Immunology Frontier Research Canter Center D ire ctor Shizuo Akira Common instructions: * Unless otherwise specified, prepare this report from the timeline of 31 March 2015. * So as to base this fiscal year’s follow-up review on the document ”Post-interim evaluation revised center project,” please prepare this report from the perspective of the revised project. * Use yen (¥) when writing monetary amounts in the report. If an exchange rate is used to calculate the yen amount, give the rate. Summary of State of WPI Center Project Progress (write within two pages) IFReC was established as a leading Institute in Immunology and Medicine in Osaka University through the support of WPI program. Our institute provides a highly equipped research platform for young next generation researchers and world premier scientists who have contributed greatly in studies of cytokines, molecular mechanisms of innate immunity, cell death, and regulation of immune system. Our mission in WPI is to accelerate immunology research as well as develop fusion studies with other fields, systems reform of the host institute, and globalization of university and our society. Research of the highest world level: IFReC has continued to publish high quality research activities in highly reputable academic journals during FY2014 in innate immunity, acquired immunity, and the immune regulatory mechanism under the prominent leadership of center director Shizuo Akira, with 195 “WPI papers”, whose author(s) can be identified as affiliated with the WPI program.
    [Show full text]
  • Tumor Apoptosis, Respectively by Fas-Fas Ligand- and Perforin-Induced Recombinant IL-12 Are Mediated Primarily Administration Of
    Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 Are Mediated Primarily by Fas-Fas Ligand- and Perforin-Induced Tumor Apoptosis, Respectively1 Wataru Hashimoto,* Tadashi Osaki,2* Haruki Okamura,‡ Paul D. Robbins,† Masashi Kurimoto,§ Shigekazu Nagata,¶ Michael T. Lotze,*† and Hideaki Tahara3*† Systemic administration of rIL-18 protein to mice significantly suppresses the growth of murine tumor cell lines. The antitumor effect of IL-18 appears to be primarily mediated by asialo GM11 cells. Since IL-18 enhances Fas ligand (FasL) expression on NK cell lines, the IL-18 antitumor effects could be mediated by FasL-induced cross-linking of Fas and subsequent tumor apoptosis. To address this question, rIL-18 or rIL-12 was administered to animals bearing the CL8-1 melanoma inoculated intradermally into wild type (wt), lymphoproliferation gene (lpr) (Fas deficient), or generalized lymphoproliferative disease gene (gld) (FasL deficient) mice. Although rIL-12 treatment retained significant antitumor effects in gld and lpr mice, those of rIL-18 administration were completely abrogated in gld but not lpr or wt mice. In vitro cytotoxicity was significantly enhanced against NK-sensitive YAC-1 cells and CL8-1 cells by rIL-18 administration to wt mice, but not to gld mice. Furthermore, rIL-18 administration augmented the cytotoxicity of liver lymphocytes harvested from perforin-deficient mice, whereas rIL-12 administration did not. Consistent with the role of this pathway, rIL-18 administration also up-regulates the expression of FasL mRNA in splenocytes. Lysis of CL8-1 cells induced by anti-Fas agonistic Ab was enhanced about 1.4-fold by IFN-g, a cytokine that is induced by IL-18 in vitro and in vivo.
    [Show full text]
  • Functional Expression of the P2X7 ATP
    Functional Expression of the P2X7 ATP Receptor Requires Eros Yuta Ryoden, Toshihiro Fujii, Katsumori Segawa and Shigekazu Nagata This information is current as of September 27, 2021. J Immunol published online 20 December 2019 http://www.jimmunol.org/content/early/2019/12/20/jimmun ol.1900448 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/12/20/jimmunol.190044 Material 8.DCSupplemental Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published December 20, 2019, doi:10.4049/jimmunol.1900448 The Journal of Immunology Functional Expression of the P2X7 ATP Receptor Requires Eros Yuta Ryoden, Toshihiro Fujii,1 Katsumori Segawa, and Shigekazu Nagata In response to extracellular ATP, the purinergic receptor P2X7 mediates various biological processes, including phosphatidylserine (PtdSer) exposure, phospholipid scrambling, dye uptake, ion transport, and IL-1b production. A genome-wide CRISPR screen for molecules responsible for ATP-induced PtdSer exposure identified a transmembrane protein, essential for reactive oxygen species (Eros), as a necessary component for P2X7 expression.
    [Show full text]
  • Mapping Multiple Mutations See Biobits Page 28
    OCTOBER 2006 www.asbmb.org Constituent Society of FASEB AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY Mapping Multiple Mutations See BioBits page 28. Why Choose 21 st Century Biochemicals For Custom Peptides and Antibodies? “…the dual phosphospecific antibody you “…of the 15 custom antibodies we ordered from your company, 13 worked. “…our in-house QC lab confirmed the Thanks for the great work!” high purity of the peptide.” Over 70 years combined experience manufacturing peptides and anti- bodies Put our expertise to work for you in a collaborative atmosphere The Pinnacle – Affinity Purified Antibodies >85% Success Rate! Peptide Sequencing Included for 100% Guaranteed Peptide Fidelity Complete 2 rabbit protocol with PhD technical support and $ 1675 epitope design ◆ From HPLC purified peptide to affinity purified antibody with no hidden charges!..........$1895 Special pricing through December 3 1, 2006 Phosphospecific Antibody Experts ◆ Custom Phosphospecific Ab’s as low as $2395 Come speak with our scientists at Neuroscience in Atlanta, GA - Booth 2127 and HUPO in Long Beach, CA - Booth 231 www.21stcenturybio.com 33 Locke Drive, Marlboro, MA 01752 Made in the P: 508.303.8222 Toll-free: 877.217.8238 U.S.A. F: 508.303.8333 E: [email protected] www.asbmb.org AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY OCTOBER 2006 Volume 5, Issue 7 features 8 Osaka Bioscience Institute: A World Leader in Scientific Research 11 JLR Looks at Systems Biology 12 Education and Professional Development ON THE COVER: Human growth hormone 14 Judith Klinman to Receive ASBMB-Merck Award residues colored by contribution to receptor 15 Scott Emr Selected for ASBMB-Avanti Award recognition: red, favorable; 16 The Chromosome Cycle green, neutral; blue, unfavorable.
    [Show full text]
  • Engulfment of Apoptotic Cells Locus-1 in a Subset of Macrophages for Expression of Developmental Endothelial
    Expression of Developmental Endothelial Locus-1 in a Subset of Macrophages for Engulfment of Apoptotic Cells This information is current as Rikinari Hanayama, Masato Tanaka, Keiko Miwa and of September 29, 2021. Shigekazu Nagata J Immunol 2004; 172:3876-3882; ; doi: 10.4049/jimmunol.172.6.3876 http://www.jimmunol.org/content/172/6/3876 Downloaded from References This article cites 49 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/172/6/3876.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Expression of Developmental Endothelial Locus-1 in a Subset of Macrophages for Engulfment of Apoptotic Cells1 Rikinari Hanayama,* Masato Tanaka,*† Keiko Miwa,*‡ and Shigekazu Nagata2*‡§ A major function of macrophages is to engulf apoptotic cells to prevent them from releasing noxious materials as they die.
    [Show full text]
  • DNA-Mediated Cyclic GMP−AMP Synthase− Dependent and −Independent Regulation of Innate Immune Responses
    DNA-Mediated Cyclic GMP−AMP Synthase− Dependent and −Independent Regulation of Innate Immune Responses This information is current as Kou Motani, Shinji Ito and Shigekazu Nagata of September 28, 2021. J Immunol 2015; 194:4914-4923; Prepublished online 8 April 2015; doi: 10.4049/jimmunol.1402705 http://www.jimmunol.org/content/194/10/4914 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2015/04/08/jimmunol.140270 Material 5.DCSupplemental References This article cites 57 articles, 19 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/194/10/4914.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology DNA-Mediated Cyclic GMP–AMP Synthase–Dependent and –Independent Regulation of Innate Immune Responses Kou Motani,*,† Shinji Ito,‡ and Shigekazu Nagata* Cytoplasmic DNA activates cyclic GMP–AMP synthase (cGAS) to produce cyclic 29-5939-59GMP–AMP dinucleotide (295 9cGAMP).
    [Show full text]
  • Swiss-Kyoto Symposium 21–22 November 2013 ETH Zurich and the University of Zurich Switzerland
    Swiss-Kyoto Symposium 21–22 November 2013 ETH Zurich and the University of Zurich Switzerland Conference Booklet ETH Global 1 Swiss-Kyoto Symposium 2013 2 Swiss-Kyoto Symposium 2013 Table of Contents Introduction 5 Welcome from Organising Institutions 6 Welcome from the Ambassador of Japan 8 Institutional Portraits 9 Programme 13 Overview of Parallel Scientific Sessions 15 Keynote Speakers’ Profiles 16 Executive Speakers’ Profiles 17 Parallel Scientific Session Programmes and Participants’ Profiles H1 Molecular and Cellular Basis of Development, Tissue Repair and Disease 21 H2 Magnetic Resonance 31 H3 Condensed Matter Physics 39 H4 Nanoelectronics and Nanophotonics 57 H5 Organic Chemistry and Materials Chemistry 67 Z1 Product Development and Manufacturing 73 Z2 Advanced Nano-/Biotechnology 81 Z3 Energy 87 Z4 Astrophysics 97 Z5 AI and Robotics 103 Z6 Natural Hazards and Disaster Prevention Research 109 U1 Virtual Ape 117 U2 Plants and Environment 123 U3 Finance and Risk 133 U4 Extentialismus heute 139 U5 Materials for Energy, Environment, and Life 145 Maps 151 General Information 154 Participants List 155 3 Swiss-Kyoto Symposium 2013 4 Swiss-Kyoto Symposium 2013 Swiss-Kyoto Symposium 2013 Introduction In 2014 Switzerland and Japan are celebrating the 150th anniversary of diplomatic relations between the two countries. Around the anniversary several cultural and scientific events are planned to foster cooperation and initiate new joint activities building on the long standing friendship. The Japanese-Swiss partnership extends to many levels with science and technology playing an important role. Building on the high innovation power, the quality of their research institutions and the strong investment in science and technology, Switzerland and Japan have established a strategic bilateral Science and Technology cooperation.
    [Show full text]
  • Necrotic Death Pathway in Fas Receptor Signaling
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Necrotic Death Pathway in Fas Receptor Signaling Hirotaka Matsumura,* Yusuke Shimizu,* Yoshiyuki Ohsawa,‡ Atsuo Kawahara,* Yasuo Uchiyama,‡ and Shigekazu Nagata*§ *Department of Genetics and ‡Department of Cell Biology and Anatomy, Osaka University Medical School, Osaka 565-0871, Japan; and §Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan Abstract. A caspase 8–deficient subline (JB6) of hu- with Fas ligand or anti–mouse Fas antibodies, the cells man Jurkat cells can be killed by the oligomerization of died, showing characteristics of apoptosis. A broad Fas-associated protein with death domain (FADD). caspase inhibitor (z-VAD–fmk) blocked the apoptotic This cell death process is not accompanied by caspase morphological changes and the release of cytochrome activation, but by necrotic morphological changes. c. However, the cells still died, and this cell death pro- Here, we show that the death effector domain of cess was accompanied by a strong reduction in ⌬⌿m, as FADD is responsible for the FADD-mediated necrotic well as necrotic morphological changes. The presence pathway. This process was accompanied by a loss of mi- of z-VAD–fmk and pyrrolidine dithiocarbamate to- tochondrial transmembrane potential (⌬⌿m), but not gether blocked cell death, suggesting that both apop- by the release of cytochrome c from mitochondria. Pyr- totic and necrotic pathways can be activated through rolidine dithiocarbamate, a metal chelator and antioxi- the Fas death receptor. dant, efficiently inhibited the FADD-induced reduction of ⌬⌿m and necrotic cell death.
    [Show full text]